ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,970Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 890

$1.08M Total Retail Price of All Prescriptions

Rank: 41 out of 890

582 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 582 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

11% of this provider’s 582 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 11,964 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LISINOPRIL 561 452 1 4
LEVOTHYROXINE SODIUM 546 422 2 2
SIMVASTATIN 433 393 3 5
AMLODIPINE BESYLATE 428 385 4 1
FUROSEMIDE 419 311 5 7
MELOXICAM 335 273 6 18
OMEPRAZOLE 314 218 7 8
TRAMADOL HCL 291 186 8 16
GABAPENTIN 279 189 9 12
HYDROCODONE-ACETAMINOPHEN 257 188 S3 10 3
NAMENDA 246 236 11 36
ATORVASTATIN CALCIUM 223 184 12 13
TRAZODONE HCL 220 145 13 40
CARVEDILOL 216 169 14 22
DONEPEZIL HCL 208 208 15 30
METFORMIN HCL 204 156 16 6
METOPROLOL TARTRATE 190 146 17 15
ALENDRONATE SODIUM 188 167 18 38
TAMSULOSIN HCL 171 138 19 32
HYDROCHLOROTHIAZIDE 171 142 19 9
METOCLOPRAMIDE HCL 168 110 21 125
ADVAIR DISKUS 156 101 22 52
CLOPIDOGREL 156 133 22 28
CLONIDINE HCL 153 130 24 35
DIOVAN 152 125 25 33
ZOLPIDEM TARTRATE 146 100 26 19
ATENOLOL 142 124 27 23
PANTOPRAZOLE SODIUM 139 88 28 34
DIGOXIN 136 127 29 65
PRAVASTATIN SODIUM 132 82 30 10
CITALOPRAM HBR 126 94 31 20
CYMBALTA 124 91 32 45
RISPERIDONE 118 77 33 78
METOPROLOL SUCCINATE 117 84 34 17
JANUVIA 116 79 35 59
POTASSIUM CHLORIDE 115 84 36 11
BUPROPION HCL SR 108 68 37 216
BYSTOLIC 106 67 38 86
KLOR-CON M20 105 89 39 72
PLAVIX 104 86 40 42
POLYETHYLENE GLYCOL 3350 101 95 41 67
SERTRALINE HCL 101 63 41 26
DIVALPROEX SODIUM 85 47 43 126
LOVAZA 83 55 44 120
FLUTICASONE PROPIONATE 81 40 45 39
AMITRIPTYLINE HCL 80 58 R 46 43
ZIPRASIDONE HCL 80 61 46 229
CIPROFLOXACIN HCL 79 70 48 58
DIOVAN HCT 79 52 48 48
TIZANIDINE HCL 79 0 48 106
GLIMEPIRIDE 78 18 51 27
CRESTOR 77 42 52 25
DILTIAZEM 24HR CD 73 72 53 156
NEXIUM 72 62 54 14
VENLAFAXINE HCL ER 72 56 54 114
FENOFIBRATE 72 42 54 74
MEGESTROL ACETATE 71 64 R 57 92
PAROXETINE HCL 70 69 58 68
NIFEDIPINE ER 70 53 58 75
ALLOPURINOL 68 37 60 31
MECLIZINE HCL 67 51 61 97
AZITHROMYCIN 67 50 61 37
SPIRIVA 66 34 63 66
LIPITOR 66 49 63 77
LANTUS 65 47 65 50
CEPHALEXIN 65 41 65 119
AVODART 65 64 65 198
DILTIAZEM 24HR ER 64 62 68 149
LOSARTAN POTASSIUM 61 46 69 29
QUETIAPINE FUMARATE 59 53 70 73
PROMETHAZINE HCL 59 28 R 70 104
MIRTAZAPINE 55 47 72 82
BENICAR 55 44 72 180
BENZTROPINE MESYLATE 55 0 R 72 196
OLANZAPINE 54 42 75 145
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 45 75 76
KLOR-CON M10 52 49 77 165
LEVOFLOXACIN 52 46 77 107
PHENYTOIN SODIUM EXTENDED 52 30 77 111
LYRICA 51 42 80 71
EXFORGE 51 32 80 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.